BLOOD TRANSFUSION REACTION IN EMERGENCY DEPARTMENT

FAHAD BAHAIDARAH *

Consultant Emergency Medicine and Prehospital Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

RAWABI IBRAHIM ASAHEIMI

Jouf University, KSA.

AMJAD ATIAH M. ALRUWAILI

King Fahad Hospital, Alhafuf, Saudi Arabia.

ALSAILEEK, ZAINAB AHMED A.

King Faisal General Hospital, Alhofuf, Alahsaa, Saudi Arabia.

AHMED HASSAN AL HUSSAIN

King Faisal General Hospital, Alhofuf, Saudi Arabia.

MOHAMMED ABDULLAH ALSALAIM

King Khalid Hospital, Najran, Saudi Arabia.

ABDULLAH SAUD ABDULLAH ALFARAJ

Dammam Medical Complex, Dammam, Saudi Arabia.

MOHAMED OMAR MOHAMED ABDELBAKI SHEHATA

Intern from BMC, KSA.

SAGR, ABDULMAJEED ADIL M.

Heraa General Hospital, Makkah, Saudi Arabia.

KHALID MOHAMMED ALTUWAYJIRI

Mental Health Hospital, Qassim, Saudi Arabia.

KHALAF MOHAMMED ALKHALAF

King Salman Hospital (ER), Saudi Arabia.

HASSAN MOHAMMED ASIRI

King Khalid Hospital, Najran, Saudi Arabia.

SULTAN ESSA ALHARBI

Qassim University, Qassim, KSA.

MISHAL AIED HUDERS ALANZY

King Salman Specialist Hospital, Hail, KSA.

MOHAMMED HUSSAIN A. ALRUWAILI

Diriyah Hospital, West Laban Primary Healthcare Centre, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Early detection, rapid cessation of the transfusion, early consultation with the hematologic and ICU departments, and fluid resuscitation are all necessary for the initial management of blood transfusion reactions. It is crucial that doctors stay current with the literature, are knowledgeable of the pathophysiology, early therapy, and hazards of each type of transfusion reaction because blood transfusions can result in major adverse consequences. Immune-mediated transfusion responses frequently result from a mismatch or incompatibility between the recipient and the transfused substance. Monitoring the patient's respiration rate, blood pressure, temperature, and pulse rate is necessary. Abnormal clinical characteristics, such as fever, rashes, or angioedema, should also be constantly evaluated.

Keywords: Angioedema, immune-mediated transfusion, pathophysiology, blood transfusion


How to Cite

BAHAIDARAH, F., ASAHEIMI, R. I., ALRUWAILI, A. A. M., A., A. Z. A., HUSSAIN, A. H. A., ALSALAIM, M. A., ALFARAJ, A. S. A., SHEHATA, M. O. M. A., M., S. A. A., ALTUWAYJIRI, K. M., ALKHALAF, K. M., ASIRI, H. M., ALHARBI, S. E., ALANZY, M. A. H., & ALRUWAILI, M. H. A. (2022). BLOOD TRANSFUSION REACTION IN EMERGENCY DEPARTMENT. UTTAR PRADESH JOURNAL OF ZOOLOGY, 43(24), 387–392. https://doi.org/10.56557/upjoz/2022/v43i243336

Downloads

Download data is not yet available.

References

Sirianni G, Perri G, Callum J, Gardner S, Berall A, Selby D. A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting. Am J Hosp Palliat Care. 2019;36(3):185-190.

[PubMed]

McClosky ME, Cimino Brown D, Weinstein NM, Chappini N, Taney MT, Marryott K, Callan MB. Prevalence of naturally occurring non-AB blood type incompatibilities in cats and influence of crossmatch on transfusion outcomes. J Vet Intern Med. 2018;32(6):1934-1942.

[PMC free article] [PubMed]

Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC. International validation of harmonized definitions for complications of blood donations. Transfusion. 2018;58(11):2589-2595.

[PubMed]

Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. How clinicians can minimize transfusion-related adverse events? Transfus Clin Biol. 2018;25(4):257-261.

[PubMed]

Py JY, Cabezon B, Sapey T, Jutant T. Unacknowledged adverse transfusion reactions: Are they a mine to dig? Transfus Clin Biol. 2018;25(1):63-72.

[PubMed]

Jacquot C, Delaney M. Efforts Toward Elimination of Infectious Agents in Blood Products. J Intensive Care Med. 2018;33(10): 543-550.

[PubMed]

Ameen R, Al-Shemmari S, Al-Humood S, et al. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion. 2003;43:1604–1610.

Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in -thalassemia major. Blood. 2008;111:583–587.

Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion. 2010;52:2220–2224.

Davies P, Robertson S, Hegde S, et al. Calculating the required transfusion volume in children. Transfusion. 2007;47:212–216.

Friedman DF, Jawad AF, Martin MB, et al. Erythro-cytapheresis to reduce iron loading in thalassemia. Blood. 2003;102: 121a.

Klein HG, Spahn DR, Carson JL. Red blood cell transfusions in clinical practice. Lancet. 2007;370:415–436.

Milkins C, Berryman J, Cantwell C, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med. 2013;23:3–35.

British Committee for Standards in Haematology. Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology. 2004;126:11– 28.

British Committee for Standards in Haematology. Guidelines on the administration of Blood Components; 2009.

British Thoracic Society/Scottish Intercollegiate Guideline Network Guidelines on the Management of Asthma; 2011.

Available: http://www.brit-thoracic.org.uk/Guidelines/Asthma-Guidelines.aspx.

Ezidiegwu C, Lauenstein K, Rosales L, Kelly K, Henry J. Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. Archives of Pathology & Laboratory Medicine. 2004;128: 991– 995.

Fry J, Arnold D, Clase C, Crowther M, Holbrook A, Traore A, Warkentin T, Heddle N. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 2010;50:1722– 1730.

Gauvin F, Lacroix J, Robillard P, Lapointe H, Hume H. Acute transfusion reactions in the pediatric intesive care unit. Transfusion. 2006;46:1899–1908.

Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations? ACP Journal Club. 2006;144:A8–A9.

Heddle N. Febrile Nonhemolytic Transfusion reactions. In: Transfusion Reactions 3rd edn (ed. by M. Popovsky). 2007;69–77.

AABB press, Bethesda, MD. ISBN 978-1-56395-244-9

Heddle N. Investigation of acute transfusion reactions. In: Practical Transfusion Medicine, 3rd edn (eds by M. Murphy & D. Pamphilon). Wiley-Blackwell, Oxford. 2009; 86– 87. ISBN 978-1-4051-8196-9

International Haemovigilance Network/ International Society for Blood transfusion. Proposed Standard Definitions for Surveillance of Non-infectious Adverse Transfusion Reactions; 2011.

Available:http://www.isbtweb.org/fileadmin/user_upload/WP_on_Haemovigilance/ISBT_definitions_final_2011__4_.pdf

NICE. Acutely ill patients in hospital. Recognition of and response to acute illness in adults in hospital. NICE clinical guideline 50. National Institute for Health and Clinical Excellence; 2007.